More than half of infants insured through Medicaid who were diagnosed with HIV within one year of life did not receive postnatal antiretroviral prophylaxis, according to new findings presented at IDWeek 2024.
Black, Hispanic and Medicaid-insured populations continue to lack equitable access to pre-exposure prophylaxis, according to new findings from Gilead Sciences presented at IDWeek 2024.
The overall vaccination rates for influenza, SARS-CoV-2 and RSV remain below 50%, with Black individuals less likely to be vaccinated than white individuals, even when living in similarly disadvantaged neighborhoods, according to new findings presented at IDWeek 2024.
The Infectious Diseases Society of America is honored to recognize 10 outstanding experts at IDWeek 2024 for their contributions to the field of infectious diseases.
The Infectious Diseases Society of America is pleased to announce Tina Tan, MD, FIDSA, FPIDS, FAAP, as the Society’s new president beginning Oct. 20.
The HIV Medicine Association is pleased to announce the election of Colleen Kelley, MD, MPH, FIDSA, as the new chair of its Board of Directors. HIVMA is dedicated to addressing health disparities and health inequities in its mission to end the HIV epidemic.
Loading...
We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.
